Rarecells Diagnostics SAS

We develop and commercialize patented, disruptive liquid biopsy tests – innovative blood tests in oncology – based on a unique cell isolation technology called ISET (Isolation by SizE of Tumor cells) and cyto-molecular profiling of Circulating Tumor Cells, for the diagnosis of multiple cancer types and personalized therapeutic. Develop breakthrough noninvasive tests for earlier cancer diagnosis based on disruptive morpho-molecular rare cells technology.